MedPath

AFTERROSC

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest

Recruiting
Conditions
Cardiac Arrest
First Posted Date
2022-11-07
Last Posted Date
2024-01-30
Lead Sponsor
AfterROSC
Target Recruit Count
4500
Registration Number
NCT05606809
Locations
🇫🇷

CHU Nantes, Nantes, Pays De Loire, France

🇫🇷

Hopital Jacques Cartier, Massy, France

🇫🇷

Clinique Ambroise Paré, Neuilly-sur-Seine, France

and more 2 locations

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

Completed
Conditions
Cardiac Arrest
First Posted Date
2019-11-19
Last Posted Date
2023-09-07
Lead Sponsor
AfterROSC
Target Recruit Count
907
Registration Number
NCT04167891
Locations
🇧🇪

ERASME, Bruxelles, Belgium

🇫🇷

CHU Amiens, Amiens, France

🇫🇷

CHU Angers, Angers, France

and more 24 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.